Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), Boston, MA – FDA Inspections
Inspection records and compliance data for Rhythm Pharmaceuticals, Inc. in Boston, Massachusetts. 2 FDA inspections on record, last inspected March 27, 2024. Publicly traded as NASDAQ: RYTM.
This profile covers Rhythm Pharmaceuticals, Inc. based in Boston, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected June 17, 2020. Last inspected March 27, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 27, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1235904 |
| June 17, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1128328 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Rhythm Pharmaceuticals, Inc.
Stock ticker
RYTM
Exchange
NASDAQ
Share price
$104.00
Market cap
$7.2B
Price as of
November 6, 2026
FEI Number
3008898878
Address
Rhythm Pharmaceuticals, Inc., 222 Berkeley St Ste 1200, Boston, Massachusetts 02116, United States
Country
United States
ID: 069dab52-a6a1-4eee-84a4-84bd1299e18d